Home Antibody All anti-AP3M2 antibodies
Anti-AP3M2 GAT Antibody Polyclonal
UltraMAB Antibodies - Validated with 10K Protein Chip
Also for AP3M2 (NM_006803)
|DNA immunization. This antibody is specific for the C Terminus Region of the target protein.|
|WB, ELISA, IHC
||WB: 0.5-1.5 ug/ml; ELISA: 1:100-1:2000; IHC: 1:10-1:2000; IHC-P 1:10-1:2000
|20 mM Potassium Phosphate, 150 mM Sodium Chloride, pH 7.0|
|The fragment used for DNA immunization was expressed in E.coli and the purified protein fragment was used for affinity purification of the antibody. (Protein A or G Sepharose)
|This antibody was generated by SDIX's Genomic Antibody Technology ® (GAT). Learn about GAT
|Homo sapiens adaptor-related protein complex 3, mu 2 subunit (AP3M2), transcript variant 2|
|AP47B; CLA20; P47B|
|This gene encodes a subunit of the heterotetrameric adaptor-related protein comlex 3 (AP-3), which belongs to the adaptor complexes medium subunits family. The AP-3 complex plays a role in protein trafficking to lysosomes and specialized organelles.|
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western Blot: AP3M2 Antibody - Western Blot was performed using affinity purified SEQer AP3M2 antibody, aa(321-418) antibody. The lanes contain 5-30ug of a whole cell extract. Final concentration of antibodies = 0.1ug/ml (1:10,000 dilution). The blot was probed overnight with the SEQer AP3M2 antibody, aa(321-418) antibody. Blot was then washed according to protocol and probed with goat-anti-Rabbit-HRP conjugate at 1:5000 dilution, washed and developed using chemiluminescence (film exposure 5-30sec). The protein was detected as represented by the band shown.
Immunohistochemistry: AP3M2 Antibody - Normal tissues showed moderate to strong cytoplasmic staining. Gastro-intestinal glandular cells, hepatocytes and the thyroid exhibited strong staining. The malignant tissues displayed mainly moderate positivity. Strong staining was observed in most cases of colo-rectal cancers but also observed in occasional cases of other malignancies. Skin cancers generally displayed weak staining. Image and statement courtesy of the Human Protein Atlas (HPA).